1-9 of 9
Angèle Kelder
Close
Sort by
Journal Articles

Specificity of Markers of Leukemia Initiating Cells with a New Multiparameter Flow Cytometry Based Appraoch; Impact for Prognostic and Therapeutic Applications

Gerrit J. Schuurhuis, PhD, Rolf Wouters, Angèle Kelder, Arjo P Rutten, Alexander N Snel, Monique Terwijn, Paul Noordhuis, PhD, Sonja Zweegman, MD, PhD, Gert J. Ossenkoppele, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1834.
https://doi.org/10.1182/blood.V116.21.1834.1834
Published: 2010
Journal Articles

Relapsed AML Patients with Mutational Shifts Harbor An Oligoclonal Primitive Cell Compartment at Presentation; Evidence for Clonal Selection towards Relapse

Costa Bachas, Gerrit Jan Schuurhuis, PhD, Zinia J. Kwidama, Angèle Kelder, Alexander N. Snel, Gertjan J. Kaspers, MD, PhD, Jacqueline Cloos, PhD
Journal: Blood
Blood (2010) 116 (21): 751.
https://doi.org/10.1182/blood.V116.21.751.751
Published: 2010
Journal Articles

Accurate Detection of Residual Leukemic Stem Cells In Remission Bone Marrow Predicts Relapse In Acute Myeloid Leukemia Patients

Monique Terwijn, Arjo P Rutten, Angèle Kelder, Alexander N Snel, Willemijn J Scholten, Sonja Zweegman, Gert J Ossenkoppele, Gerrit J Schuurhuis
Journal: Blood
Blood (2010) 116 (21): 759.
https://doi.org/10.1182/blood.V116.21.759.759
Published: 2010
Journal Articles

High Prognostic Impact of Flowcytometric Minimal Residual Disease Detection In Acute Myeloid Leukemia: Prospective Data From the HOVON/SAKK 42a Study

Monique Terwijn, Angèle Kelder, Wim L.J. van Putten, Alexander N. Snel, Vincent H.J. van der elden, PhD, Rik A. Brooimans, PhD, Nancy Boeckx, MD, PhD, Frank W.M.B. Preijers, PhD, Bob Löwenberg, MD, PhD, Angelika M. Dräger, PhD, Peter C. Huijgens, MD, PhD, Peter J.M Valk, PhD, Johan Maertens, MD, Thomas Pabst, MD, PhD, Gert J. Ossenkoppele, MD, PhD, Gerrit J. Schuurhuis, PhD
Journal: Blood
Blood (2010) 116 (21): 760.
https://doi.org/10.1182/blood.V116.21.760.760
Published: 2010
Journal Articles

The Prognostic Value of CD34 Expression In Acute Myeloid Leukemia. A Mystery Solved

Gerrit J. Schuurhuis, PhD, Angèle Kelder, Monique Terwijn, Arjo P Rutten, Linda Smit, PhD, Sonja Zweegman, MD, PhD, Gert Ossenkoppele, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2725.
https://doi.org/10.1182/blood.V116.21.2725.2725
Published: 2010
Journal Articles

Leukemic Stem Cell Assessment in Remission Bone Marrow of Acute Myeloid Leukemia Patients Is a New Prognostic Parameter.

Monique Terwijn, Angèle Kelder, Arjo P Rutten, Alexander N Snel, Willemijn Scholten, Sonja Zweegman, MD, PhD, Gert Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2009) 114 (22): 399.
https://doi.org/10.1182/blood.V114.22.399.399
Published: 2009
Journal Articles

High Leukemic Stem Cell Frequency in Remission Bone Marrow Predicts Poor Outcome in Acute Myeloid Leukemia

Terwi J Monique, MSc, Angèle Kelder, Arjo P Rutten, Gert J Ossenkoppele, MD, PhD, Sonja Zweegman, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2008) 112 (11): 2537.
https://doi.org/10.1182/blood.V112.11.2537.2537
Published: 2008
Journal Articles

Specific Detection of Aberrant and Normal Stem Cells in Acute Myeloid Leukemia Patients Opens the Way for Defining Highly Specific Targets for Stem Cell Therapy.

J Monique Terwi, MSc, Angèle Kelder, Arjo P Rutten, Sonja Zweegman, MD, PhD, Gert J Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2008) 112 (11): 1353.
https://doi.org/10.1182/blood.V112.11.1353.1353
Published: 2008
Journal Articles

The Novel AML Stem Cell Associated Antigen CLL-1 Discriminates between Normal and Leukemic Stem Cells.

Anna van Rhenen, Nicole Feller, Angèle Kelder, Guus Westra, Lex Bakker, PhD, Gert Ossenkoppele, MD, PhD, Gerrit Jan Schuurhuis, PhD
Journal: Blood
Blood (2005) 106 (11): 4.
https://doi.org/10.1182/blood.V106.11.4.4
Published: 2005